Correlation Between Memphis Pharmaceuticals and Orascom Construction

Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Orascom Construction at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Orascom Construction into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Memphis Pharmaceuticals and Orascom Construction PLC, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Orascom Construction and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Orascom Construction. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Orascom Construction.

Diversification Opportunities for Memphis Pharmaceuticals and Orascom Construction

0.0

Correlation Coefficient

Memphis Pharmaceuticals  Orascom Construction

Pay attention - limited upside

The 3 months correlation between Memphis and Orascom is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Orascom Construction PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orascom Construction PLC and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Orascom Construction. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orascom Construction PLC has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Orascom Construction go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Orascom Construction

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to generate 3.17 times more return on investment than Orascom Construction. However, Memphis Pharmaceuticals is 3.17 times more volatile than Orascom Construction PLC. It trades about 0.2 of its potential returns per unit of risk. Orascom Construction PLC is currently generating about 0.05 per unit of risk. If you would invest  5,257  in Memphis Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  2,820  from holding Memphis Pharmaceuticals or generate 53.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Memphis Pharmaceuticals  vs.  Orascom Construction PLC

Memphis Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Orascom Construction PLC

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Orascom Construction PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Orascom Construction is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Memphis Pharmaceuticals and Orascom Construction

The main advantage of trading using opposite Memphis Pharmaceuticals and Orascom Construction positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Orascom Construction can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orascom Construction will offset losses from the drop in Orascom Construction's long position.

The idea behind Memphis Pharmaceuticals and Orascom Construction PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.